{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:39:18Z","timestamp":1790872758878,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Homocysteine and cysteine are considered as risk factors of cardiovascular disease. Homocysteine influences the liver expression of ApoA-I and decreases its blood level and HDL in genetic mice model. We aimed therefore to evaluate whether homocysteine and cysteine are associated with lipid parameters, and the joint effects of them on the risk of coronary artery disease (CAD). Plasma total homocysteine (tHcy), cysteine (tCys) and lipid markers were measured in 2058 consecutive coronary artery angiographic patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Plasma tHcy but not tCys correlated negatively with ApoA-I (r = -0.153, <jats:italic>P<\/jats:italic> &lt; 0.001) and with HDL cholesterol (r = -0.148, <jats:italic>P<\/jats:italic> &lt; 0.001), and correlated positively with the risk of CAD (OR: 1.61; 95% confidence interval; 1.26 to 2.05). Combination of high tHcy and high tCys levels was associated with decreased ApoA-I and HDL cholesterol levels, and with increased risk of CAD (OR: 1.696, 95% CI (1.301-2.211)). Furthermore, low HDL cholesterol combined with low tHcy or high tHcy all had increased risk for CAD (OR: 1.254, 95% CI (1.114-1.565); OR: 1.332, 95% CI (1.093-1.624); respectively) whereas high HDL cholesterol counteracted the harmful effect of high tHcy on the risk of CAD. However, only the combination of high tHcy and high ApoA-I had an increased risk for CAD (OR: 1.438, 95% CI (1.170-1.768)).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The association of homocysteine and cysteine, ApoA-I or HDL cholesterol and their joint effects provide new insights on its role on CAD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1476-511x-10-137","type":"journal-article","created":{"date-parts":[[2011,8,12]],"date-time":"2011-08-12T18:21:59Z","timestamp":1313173319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Relationship between lipid profiles and plasma total homocysteine, cysteine and the risk of coronary artery disease in coronary angiographic subjects"],"prefix":"10.1186","volume":"10","author":[{"given":"Yunjun","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,12]]},"reference":[{"issue":"17","key":"529_CR1","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","volume":"324","author":"R Clarke","year":"1991","unstructured":"Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I: Hyperhomocysteinemia: an independent risk factor for vascular disease. The New England journal of medicine. 1991, 324 (17): 1149-1155. 10.1056\/NEJM199104253241701","journal-title":"The New England journal of medicine"},{"issue":"3","key":"529_CR2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.amjcard.2007.03.046","volume":"100","author":"M Ni","year":"2007","unstructured":"Ni M, Zhang XH, Jiang SL, Zhang Y: Homocysteinemia as an independent risk factor in the Chinese population at a high risk of coronary artery disease. The American journal of cardiology. 2007, 100 (3): 455-458. 10.1016\/j.amjcard.2007.03.046","journal-title":"The American journal of cardiology"},{"issue":"15","key":"529_CR3","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1056\/NEJMoa060900","volume":"354","author":"E Lonn","year":"2006","unstructured":"Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C: Homocysteine lowering with folic acid and B vitamins in vascular disease. The New England journal of medicine. 2006, 354 (15): 1567-1577.","journal-title":"The New England journal of medicine"},{"issue":"2","key":"529_CR4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ajcn\/72.2.315","volume":"72","author":"L Brattstrom","year":"2000","unstructured":"Brattstrom L, Wilcken DE: Homocysteine and cardiovascular disease: cause or effect?. The American journal of clinical nutrition. 2000, 72 (2): 315-323.","journal-title":"The American journal of clinical nutrition"},{"issue":"2","key":"529_CR5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ajcn\/72.2.324","volume":"72","author":"PM Ueland","year":"2000","unstructured":"Ueland PM, Refsum H, Beresford SA, Vollset SE: The controversy over homocysteine and cardiovascular risk. The American journal of clinical nutrition. 2000, 72 (2): 324-332.","journal-title":"The American journal of clinical nutrition"},{"issue":"2-3","key":"529_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0021-9150(89)90118-4","volume":"79","author":"A Araki","year":"1989","unstructured":"Araki A, Sako Y, Fukushima Y, Matsumoto M, Asada T, Kita T: Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects. Atherosclerosis. 1989, 79 (2-3): 139-146. 10.1016\/0021-9150(89)90118-4","journal-title":"Atherosclerosis"},{"issue":"1","key":"529_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0021-9150(99)00128-8","volume":"146","author":"N Jacob","year":"1999","unstructured":"Jacob N, Bruckert E, Giral P, Foglietti MJ, Turpin G: Cysteine is a cardiovascular risk factor in hyperlipidemic patients. Atherosclerosis. 1999, 146 (1): 53-59. 10.1016\/S0021-9150(99)00128-8","journal-title":"Atherosclerosis"},{"issue":"21","key":"529_CR8","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1161\/01.CIR.103.21.2544","volume":"103","author":"L El-Khairy","year":"2001","unstructured":"El-Khairy L, Ueland PM, Refsum H, Graham IM, Vollset SE: Plasma total cysteine as a risk factor for vascular disease: The European Concerted Action Project. Circulation. 2001, 103 (21): 2544-2549.","journal-title":"Circulation"},{"issue":"6 Pt 1","key":"529_CR9","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1373\/49.6.895","volume":"49","author":"L El-Khairy","year":"2003","unstructured":"El-Khairy L, Vollset SE, Refsum H, Ueland PM: Plasma total cysteine, mortality, and cardiovascular disease hospitalizations: the Hordaland Homocysteine Study. Clinical chemistry. 2003, 49 (6 Pt 1): 895-900.","journal-title":"Clinical chemistry"},{"issue":"Suppl 1","key":"529_CR10","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1038\/sj.cdd.4401451","volume":"11","author":"RC Austin","year":"2004","unstructured":"Austin RC, Lentz SR, Werstuck GH: Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell death and differentiation. 2004, 11 (Suppl 1): S56-64.","journal-title":"Cell death and differentiation"},{"issue":"6","key":"529_CR11","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1161\/01.RES.0000242559.42077.22","volume":"99","author":"D Liao","year":"2006","unstructured":"Liao D, Tan H, Hui R, Li Z, Jiang X, Gaubatz J, Yang F, Durante W, Chan L, Schafer AI: Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance. Circulation research. 2006, 99 (6): 598-606. 10.1161\/01.RES.0000242559.42077.22","journal-title":"Circulation research"},{"issue":"4","key":"529_CR12","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1161\/01.RES.0000204825.66410.0b","volume":"98","author":"LG Mikael","year":"2006","unstructured":"Mikael LG, Genest J, Rozen R: Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease. Circulation research. 2006, 98 (4): 564-571. 10.1161\/01.RES.0000204825.66410.0b","journal-title":"Circulation research"},{"issue":"50","key":"529_CR13","doi-asserted-by":"publisher","first-page":"31872","DOI":"10.1074\/jbc.272.50.31872","volume":"272","author":"XF Huang","year":"1997","unstructured":"Huang XF, Shelness GS: Identification of cysteine pairs within the amino-terminal 5% of apolipoprotein B essential for hepatic lipoprotein assembly and secretion. The Journal of biological chemistry. 1997, 272 (50): 31872-31876. 10.1074\/jbc.272.50.31872","journal-title":"The Journal of biological chemistry"},{"issue":"1","key":"529_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/taap.1996.0191","volume":"140","author":"CV Smith","year":"1996","unstructured":"Smith CV, Jones DP, Guenthner TM, Lash LH, Lauterburg BH: Compartmentation of glutathione: implications for the study of toxicity and disease. Toxicology and applied pharmacology. 1996, 140 (1): 1-12. 10.1006\/taap.1996.0191","journal-title":"Toxicology and applied pharmacology"},{"issue":"21","key":"529_CR15","doi-asserted-by":"crossref","first-page":"10098","DOI":"10.1016\/S0021-9258(18)61082-8","volume":"262","author":"JW Heinecke","year":"1987","unstructured":"Heinecke JW, Rosen H, Suzuki LA, Chait A: The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. The Journal of biological chemistry. 1987, 262 (21): 10098-10103.","journal-title":"The Journal of biological chemistry"},{"issue":"4 Suppl","key":"529_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1161\/01.CIR.51.4.5","volume":"51","author":"WG Austen","year":"1975","unstructured":"Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, McGoon DC, Murphy ML, Roe BB: A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation. 1975, 51 (4 Suppl): 5-40.","journal-title":"Circulation"},{"issue":"1-2","key":"529_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/0378-4347(91)80407-4","volume":"565","author":"JB Ubbink","year":"1991","unstructured":"Ubbink JB, Hayward Vermaak WJ, Bissbort S: Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. Journal of chromatography. 1991, 565 (1-2): 441-446. 10.1016\/0378-4347(91)80407-4","journal-title":"Journal of chromatography"},{"key":"529_CR18","doi-asserted-by":"crossref","unstructured":"Gueant-Rodriguez RM, Spada R, Moreno-Garcia M, Anello G, Bosco P, Lagrost L, Romano A, Elia M, Gueant JL: Homocysteine is a determinant of ApoA-I and both are associated with ankle brachial index, in an ambulatory elderly population. Atherosclerosis. 214 (2): 480-485.","DOI":"10.1016\/j.atherosclerosis.2010.11.031"},{"issue":"6","key":"529_CR19","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/ajcn\/70.6.1016","volume":"70","author":"L El-Khairy","year":"1999","unstructured":"El-Khairy L, Ueland PM, Nygard O, Refsum H, Vollset SE: Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study. The American journal of clinical nutrition. 1999, 70 (6): 1016-1024.","journal-title":"The American journal of clinical nutrition"},{"issue":"3","key":"529_CR20","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/ajcn\/88.3.738","volume":"88","author":"AK Elshorbagy","year":"2008","unstructured":"Elshorbagy AK, Nurk E, Gjesdal CG, Tell GS, Ueland PM, Nygard O, Tverdal A, Vollset SE, Refsum H: Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: does cysteine link amino acid and lipid metabolism?. The American journal of clinical nutrition. 2008, 88 (3): 738-746.","journal-title":"The American journal of clinical nutrition"},{"key":"529_CR21","unstructured":"Elshorbagy AK, Valdivia-Garcia M, Graham IM, Palma Reis R, Sales Luis A, Smith AD, Refsum H: The association of fasting plasma sulfur-containing compounds with BMI, serum lipids and apolipoproteins. Nutr Metab Cardiovasc Dis."},{"issue":"7","key":"529_CR22","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/oby.2008.671","volume":"17","author":"AK Elshorbagy","year":"2009","unstructured":"Elshorbagy AK, Refsum H, Smith AD, Graham IM: The association of plasma cysteine and gamma-glutamyltransferase with BMI and obesity. Obesity (Silver Spring, Md. 2009, 17 (7): 1435-1440.","journal-title":"Obesity (Silver Spring, Md"},{"issue":"22","key":"529_CR23","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1001\/jama.1997.03540460039030","volume":"277","author":"IM Graham","year":"1997","unstructured":"Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B: Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. Jama. 1997, 277 (22): 1775-1781. 10.1001\/jama.277.22.1775","journal-title":"Jama"},{"issue":"17","key":"529_CR24","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1001\/jama.299.17.2027","volume":"299","author":"CM Albert","year":"2008","unstructured":"Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE: Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. Jama. 2008, 299 (17): 2027-2036. 10.1001\/jama.299.17.2027","journal-title":"Jama"},{"issue":"7","key":"529_CR25","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1001\/jama.300.7.795","volume":"300","author":"M Ebbing","year":"2008","unstructured":"Ebbing M, Bleie O, Ueland PM, Nordrehaug JE, Nilsen DW, Vollset SE, Refsum H, Pedersen EK, Nygard O: Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. Jama. 2008, 300 (7): 795-804. 10.1001\/jama.300.7.795","journal-title":"Jama"},{"issue":"10","key":"529_CR26","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1093\/jn\/124.10.1934","volume":"124","author":"AB Guttormsen","year":"1994","unstructured":"Guttormsen AB, Schneede J, Fiskerstrand T, Ueland PM, Refsum HM: Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects. The Journal of nutrition. 1994, 124 (10): 1934-1941.","journal-title":"The Journal of nutrition"},{"issue":"10","key":"529_CR27","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.freeradbiomed.2003.07.001","volume":"35","author":"R Kinscherf","year":"2003","unstructured":"Kinscherf R, Cafaltzis K, Roder F, Hildebrandt W, Edler L, Deigner HP, Breitkreutz R, Feussner G, Kreuzer J, Werle E: Cholesterol levels linked to abnormal plasma thiol concentrations and thiol\/disulfide redox status in hyperlipidemic subjects. Free radical biology & medicine. 2003, 35 (10): 1286-1292. 10.1016\/j.freeradbiomed.2003.07.001","journal-title":"Free radical biology & medicine"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-511X-10-137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T16:00:48Z","timestamp":1630512048000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/1476-511X-10-137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,12]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["529"],"URL":"https:\/\/doi.org\/10.1186\/1476-511x-10-137","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,12]]},"assertion":[{"value":"11 July 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"137"}}